文献速递白血病

维A酸与三氧化二砷使急性早幼粒细胞白血病细胞对ER应激敏感

Retinoic acid and arsenic trioxide sensitize acute promyelocytic leukemia cells to ER stress.
PubMed 文献 · Leukemia · 2017-08-04

该研究显示,维A酸(RA)诱导人白血病细胞系及原代原始细胞分化后,可大幅增加其对内质网(ER)应激诱导药物的敏感性;PERK通路在ER应激反应中起主要保护作用;低量药理性ER应激足以增强三氧化二砷(ATO)毒性,使ATO在RA敏感和RA耐药的APL细胞系中于无ER应激时无效的剂量下有效诱导凋亡。

要点

  • RA诱导分化可增加白血病细胞对ER应激诱导药物的敏感性
  • PERK通路在ER应激反应中起主要保护作用
  • 低量ER应激足以增强ATO毒性并诱导RA敏感及耐药APL细胞凋亡

核心结论

  • RA诱导的人白血病细胞系及原代原始细胞分化可显著增加其对ER应激诱导药物的敏感性。
  • PERK通路在ER应激反应中起主要保护作用。
  • 低量药理性ER应激足以强烈增加ATO毒性,使ATO在RA敏感和RA耐药APL细胞系中于无ER应激时无效的剂量下有效诱导凋亡。
  • 研究结果将ER应激相关通路确定为AML新治疗策略探索中的潜在靶点。

研究设计与样本

  • 研究使用人白血病细胞系及原代原始细胞进行体外实验。

主要发现

  • RA诱导分化的人白血病细胞系及原代原始细胞对ER应激诱导药物的敏感性大幅增加,该剂量在无RA时无毒性。
  • PERK通路在ER应激反应中起主要保护作用。
  • 低量药理性ER应激足以强烈增加ATO毒性。
  • 在ER应激存在时,ATO在RA敏感和RA耐药APL细胞系中于无ER应激时无效的剂量下有效诱导凋亡。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Retinoic acid (RA) in association with chemotherapy or with arsenic trioxide (ATO) results in high cure rates of acute promyelocytic leukemia (APL). We show that RA-induced differentiation of human leukemic cell lines and primary blasts dramatically increases their sensitivity to endoplasmic reticulum (ER) stress-inducing drugs at doses that are not toxic in the absence of RA. In addition, we demonstrate that the PERK pathway, triggered in response to ER stress, has a major protective role. Moreover, low amounts of pharmacologically induced ER stress are sufficient to strongly increase ATO toxicity. Indeed, in the presence of ER stress, ATO efficiently induced apoptosis in RA-sensitive and RA-resistant APL cell lines, at doses ineffective in the absence of ER stress. Our findings identify the ER stress-related pathways as potential targets in the search for novel therapeutic strategies in AML.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Masciarelli S, Capuano E, Ottone T, et al. Retinoic acid and arsenic trioxide sensitize acute promyelocytic leukemia cells to ER stress. Leukemia. 2017. PMID: 28776567. doi:10.1038/leu.2017.231

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。